# BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA

> **NCT07570394** · — · NOT_YET_RECRUITING · sponsor: **AstraZeneca** · enrollment: 600 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07570394
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-31
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07570394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07570394, "BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07570394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*